You are here

Article Text

Article menu
Download PDFPDF
Unusual association of diseases/symptoms
CASE REPORT
Unusual case of unilateral conductive hearing loss: chronic lymphocytic leukaemia
  1. Amelia Leigh Davis1,
  2. Shane Gangatharan2,3,
  3. Jafri Kuthubutheen1,4
  1. 1School of Surgery, University of Western Australia, Crawley, Western Australia, Australia
  2. 2School of Pathology and Laboratory Medicine, University of Western Australia, Nedlands, Western Australia, Australia
  3. 3Australian Clinical Labs, Osborne Park, Western Australia, Australia
  4. 4Otolaryngology Head and Neck Surgery, Fiona Stanley Hospital, Perth, Western Australia, Australia
  1. Correspondence to Dr Jafri Kuthubutheen, jafri.kuth{at}gmail.com

Summary

This presentation reports a novel case of chronic lymphocytic leukaemia (CLL), presenting with an early cutaneous lesion within the external auditory canal, in a patient being assessed for conductive hearing loss. It has previously been reported that infiltrative CLL can involve the head and neck; however, isolated external ear canal involvement is rare. Given that the incidence of CLL in Australia is rising, this case highlights the importance of considering CLL as a differential diagnosis for presentations of unilateral conductive hearing loss.

  • ear, nose and throat/otolaryngology
  • head and neck cancer

https://doi.org/10.1136/bcr-2017-223444

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors All persons who meet authorship criteria are listed as authors, and all authors certify that they have participated sufficiently in the work to take public responsibility for the content, including participation in the concept, design, analysis, writing or revision of the manuscript. Furthermore, each author certifies that this material or similar material has not been and will not be submitted to or published in any other publication before its appearance in the British Medical Journal (BMJ).The authors have contributed as follows: (1) Concept and design: JK and SG; (2) Acquisition of data: JK and SG; (3) Analysis and interpretation of clinical data: JK and SG; (4) Drafting the manuscript: ALD; (5) Revising the manuscript: ALD, JK and SG; (6) Approval of the version of the manuscript to be published: ALD, JK and SG. We have not received contributions from non-authors.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent Obtained.

    • Provenance and peer review Not commissioned; externally peer reviewed.